ArticleHepatology communications2017

Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.

Erin K Spengler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.